ClinicalTrials.govpublic full text
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma
bronchial asthma, omalizumab, humanized monoclonal antibodies, safety, equivalence, biosimilar, anti-allergic agents, anti-asthmatic agents, respiratory system agents, hypersensitivity, immune system diseases, urticaria
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 968799
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.